NICE has published draft guidance recommending AstraZeneca’s anti-clotting drug Brilique (ticagrelor 60 mg) with aspirin for people who have had a heart attack. A higher 90mg dose of the drug is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback